Changing TACTICS in intermediate HCC: TACE plus sorafenib.
Options
BORIS DOI
Publisher DOI
PubMed ID
32169908
Date of Publication
2020-08
Publication Type
Article
Subject(s)
Keyword(s)
cancer liver
Language(s)
en
Series
Gut
Publisher
BMJ Publishing Group
ISSN
0017-5749
Access(Rights)
open.access